Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Myelofibrosis, Polycythaemia, Thrombocythaemia
Closed
Phase 1
This trial is looking at INC424 for people with myelofibrosis and a low platelet count.
Myelofibrosis (pronounced my-eh-lo-fy-bro-sis) is a rare blood disorder. It is a condition that causes scarring of the . A small number of people with myelofibrosis go on to develop acute myeloid leukaemia.
Recruitment start: 20 June 2011
Recruitment end: 2 March 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Claire Harrison
Experimental Cancer Medicine Centre (ECMC)
Novartis
Last reviewed: 6 April 2017
CRUK internal database number: 8374
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
